BETA
BETA
NLSP
NLS Pharmaceutics AG
NLSPW5
$0.04arrow_drop_down8.88%-$0.00
Penny Stock
NLSP
NLSPW5
$0.04
arrow_drop_down8.88%Performance History
| Key Stats | |
|---|---|
| Open | $0.05 |
| Prev. Close | $0.04 |
| EPS | - |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $1.56M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.04 | 0.05 |
| 52 Week Range | 0.01 | 0.17 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | - |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
Price$23.75
Perf. (24h)
arrow_drop_down0.34%-$0.08
Market Cap$36.81B
Price$23.39
Perf. (24h)
arrow_drop_up0.30%$0.07
Market Cap$36.68B
Price$25.03
Perf. (24h)
arrow_drop_up0.12%$0.03
Market Cap$12.73B
About NLS Pharmaceutics AG (NLSPW)
- Sector
- Industry
- CEO
- Headquarters
- Employees
- 0
- Exchange
- NASDAQ
Keep an eye on NLS Pharmaceutics AG
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is NLS Pharmaceutics AG's (NLSPW) price per share?
The current price per share for NLS Pharmaceutics AG (NLSPW) is $0.04. The stock has seen a price change of -$0 recently, indicating a -8.89% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for NLS Pharmaceutics AG (NLSPW)?
For NLS Pharmaceutics AG (NLSPW), the 52-week high is $0.17, which is 314.63% from the current price. The 52-week low is $0.01, the current price is 272.73% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is NLS Pharmaceutics AG (NLSPW) a growth stock?
NLS Pharmaceutics AG (NLSPW) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying NLS Pharmaceutics AG as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is NLS Pharmaceutics AG (NLSPW) stock price performance year to date (YTD)?
As of the latest data, NLS Pharmaceutics AG (NLSPW) has a year-to-date price change of -41.43%. Over the past month, the stock has experienced a price change of 31.83%. Over the last three months, the change has been 5.13%. Over the past six months, the figure is -50.3%.
help
Is NLS Pharmaceutics AG (NLSPW) a profitable company?
NLS Pharmaceutics AG (NLSPW) has a net income of -$12.17M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$11.81M. Furthermore, the EBITDA is -$11.8M.
help
What is the market capitalization of NLS Pharmaceutics AG (NLSPW)?
NLS Pharmaceutics AG (NLSPW) has a market capitalization of $1.56M. The average daily trading volume is 730, indicating the stock's liquidity and investor engagement.
News
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.